Related Experiment Video
Updated: Jun 17, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke
Timothy J Bernard1, Laura Z Fenton, Susan D Apkon
1Department of Pediatrics, Section of Child Neurology, Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Denver and The Children's Hospital, Aurora, CO 80045-0507, USA. timothy.bernard@ucdenver.edu
Insights
Biomarkers like D-dimer and C-reactive protein (CRP) are often elevated in children with arterial ischemic stroke (AIS). Elevated D-dimer levels may indicate a cardioembolic cause in pediatric AIS.
Area of Science:
- Pediatric Neurology
- Vascular Neurology
- Biomarker Discovery
Background:
- Arterial ischemic stroke (AIS) in children is a significant cause of long-term disability.
- Understanding the underlying pathophysiology and identifying risk factors for recurrence are crucial in pediatric AIS.
- Hypercoagulability and inflammation are suspected contributors to AIS in children.
Purpose of the Study:
- To investigate the prevalence of hypercoagulability and inflammation biomarkers in acute childhood-onset AIS.
- To determine if these biomarkers differ among specific etiologic subtypes of pediatric AIS.
- To assess the utility of D-dimer in identifying cardioembolic AIS in children.
Main Methods:
- Prospective/retrospective cohort study of 50 children with acute AIS (2005-2009).
- Serial evaluation of D-dimer, factor VIII (FVIII) activity, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR).
- Classification of patients by stroke subtype: cardioembolic, moyamoya, non-moyamoya arteriopathy, or other.
Main Results:
- D-dimer and CRP were frequently elevated in acute childhood AIS, decreasing over time.
- Acute D-dimer levels were significantly higher in cardioembolic AIS compared to noncardioembolic AIS (P = .002).
- D-dimer > or = 0.50 microg/mL showed 78% sensitivity and 79% specificity for cardioembolic AIS.
Conclusions:
- D-dimer and CRP are potential biomarkers for determining the cause and predicting the outcome of childhood AIS.
- Further research is warranted to explore the role of these and other biomarkers in pediatric AIS.
- These findings contribute to understanding the inflammatory and hypercoagulable states associated with pediatric stroke.
Objective:
To test the hypothesis that acute elevations of biomarkers of hypercoagulability and inflammation are common in children with arterial ischemic stroke (AIS), particularly among etiologic subtypes that carry an increased risk of recurrent stroke.
Study Design:
In this prospective/retrospective institutional-based cohort study of acute childhood-onset AIS (n = 50) conducted between 2005 and 2009, D-dimer, factor VIII (FVIII) activity, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were serially evaluated at the time of clinical blood sampling. Patients were classified by stroke subtype as cardioembolic, moyamoya, non-moyamoya arteriopathy, or other.
Results:
Both D-dimer and CRP were frequently elevated in acute childhood-onset AIS and exhibited a decreasing trend with time. Acute D-dimer levels were significantly higher in cardioembolic AIS compared with noncardioembolic AIS (median, 2.04 microg/mL [range 0.54-4.54 microg/mL] vs 0.32 microg/mL [0.22-3.18 microg/mL]; P = .002). At an optimal threshold of > or = 0.50 microg/mL, the sensitivity and specificity of D-dimer for cardioembolic subtype were 78% and 79%, respectively.
Conclusions:
Our findings identify D-dimer and CRP as candidate biomarkers for etiology and prognosis in childhood-onset AIS. Further studies should investigate the role of these and other biomarkers of hypercoagulability and inflammation in childhood-onset AIS.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction